Episode Details
Back to Episodes
Raymond James Biotech Innovation Summit: Checking in with Vera's Founder & CEO Marshall Fordyce ahead of the July 7 FDA decision date for the APRIL & BAFF targeting IgAN treatment Atacicept
Published 5 months ago
Description
He reminds us of the unmet need for this type of therapy and discusses the planning that Vera has been doing ahead of the decision date.